![Anthony M. Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony M.
Kim formerly worked at NovoCure GmbH, as Vice President-Global Commercial Development and RELIEF THERAPEUTICS Holding SA, as Senior VP & Head-US Commercial Operations from 2021 to 2023.
Mr. Kim received his undergraduate degree from Harvard University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Bedrijven | Functie | Einde |
|---|---|---|
| MINDMAZE THERAPEUTICS HOLDING SA | Corporate Officer/Principal | 01-01-2023 |
NovoCure GmbH
 NovoCure GmbH Pharmaceuticals: MajorHealth Technology Develops proprietary therapy | Corporate Officer/Principal | 01-12-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RELIEF THERAPEUTICS Holding SA
 RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
NovoCure GmbH
NovoCure GmbH Pharmaceuticals: MajorHealth Technology Develops proprietary therapy | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
